Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health (K24-AI145661, 5T32AI052074-13)

This publication has 20 references indexed in Scilit: